nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—Atrioventricular block complete—Hydrochlorothiazide—nephrolithiasis	0.0704	0.0704	CcSEcCtD
Flecainide—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0501	0.0501	CcSEcCtD
Flecainide—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0321	0.0321	CcSEcCtD
Flecainide—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0246	0.0246	CcSEcCtD
Flecainide—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0222	0.0222	CcSEcCtD
Flecainide—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0219	0.0219	CcSEcCtD
Flecainide—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.0203	0.0203	CcSEcCtD
Flecainide—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0192	0.0192	CcSEcCtD
Flecainide—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0189	0.0189	CcSEcCtD
Flecainide—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0188	0.0188	CcSEcCtD
Flecainide—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0178	0.0178	CcSEcCtD
Flecainide—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0177	0.0177	CcSEcCtD
Flecainide—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0168	0.0168	CcSEcCtD
Flecainide—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.015	0.015	CcSEcCtD
Flecainide—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0144	CcSEcCtD
Flecainide—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0142	0.0142	CcSEcCtD
Flecainide—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0141	0.0141	CcSEcCtD
Flecainide—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0139	CcSEcCtD
Flecainide—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0138	CcSEcCtD
Flecainide—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0135	CcSEcCtD
Flecainide—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0135	CcSEcCtD
Flecainide—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0134	CcSEcCtD
Flecainide—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0131	CcSEcCtD
Flecainide—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0128	CcSEcCtD
Flecainide—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0126	CcSEcCtD
Flecainide—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0123	CcSEcCtD
Flecainide—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0119	CcSEcCtD
Flecainide—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0115	CcSEcCtD
Flecainide—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0115	CcSEcCtD
Flecainide—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0109	CcSEcCtD
Flecainide—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0106	CcSEcCtD
Flecainide—Tension—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0105	CcSEcCtD
Flecainide—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0105	CcSEcCtD
Flecainide—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0104	CcSEcCtD
Flecainide—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Flecainide—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Flecainide—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00997	0.00997	CcSEcCtD
Flecainide—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00969	0.00969	CcSEcCtD
Flecainide—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00966	0.00966	CcSEcCtD
Flecainide—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00964	0.00964	CcSEcCtD
Flecainide—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00962	0.00962	CcSEcCtD
Flecainide—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0095	0.0095	CcSEcCtD
Flecainide—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00945	0.00945	CcSEcCtD
Flecainide—Cough—Hydrochlorothiazide—nephrolithiasis	0.00938	0.00938	CcSEcCtD
Flecainide—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00915	0.00915	CcSEcCtD
Flecainide—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00915	0.00915	CcSEcCtD
Flecainide—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00915	0.00915	CcSEcCtD
Flecainide—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00912	0.00912	CcSEcCtD
Flecainide—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00904	0.00904	CcSEcCtD
Flecainide—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00895	0.00895	CcSEcCtD
Flecainide—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00885	0.00885	CcSEcCtD
Flecainide—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00877	0.00877	CcSEcCtD
Flecainide—Shock—Hydrochlorothiazide—nephrolithiasis	0.00863	0.00863	CcSEcCtD
Flecainide—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00859	0.00859	CcSEcCtD
Flecainide—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00856	0.00856	CcSEcCtD
Flecainide—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00848	0.00848	CcSEcCtD
Flecainide—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00836	0.00836	CcSEcCtD
Flecainide—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.0082	0.0082	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00799	0.00799	CcSEcCtD
Flecainide—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00793	0.00793	CcSEcCtD
Flecainide—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00788	0.00788	CcSEcCtD
Flecainide—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00782	0.00782	CcSEcCtD
Flecainide—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0078	0.0078	CcSEcCtD
Flecainide—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00772	0.00772	CcSEcCtD
Flecainide—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00763	0.00763	CcSEcCtD
Flecainide—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00756	0.00756	CcSEcCtD
Flecainide—Pain—Hydrochlorothiazide—nephrolithiasis	0.0075	0.0075	CcSEcCtD
Flecainide—Constipation—Hydrochlorothiazide—nephrolithiasis	0.0075	0.0075	CcSEcCtD
Flecainide—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00723	0.00723	CcSEcCtD
Flecainide—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00717	0.00717	CcSEcCtD
Flecainide—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00697	0.00697	CcSEcCtD
Flecainide—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00694	0.00694	CcSEcCtD
Flecainide—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00694	0.00694	CcSEcCtD
Flecainide—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00629	0.00629	CcSEcCtD
Flecainide—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00621	0.00621	CcSEcCtD
Flecainide—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.006	0.006	CcSEcCtD
Flecainide—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.0058	0.0058	CcSEcCtD
Flecainide—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00558	0.00558	CcSEcCtD
Flecainide—Rash—Hydrochlorothiazide—nephrolithiasis	0.00553	0.00553	CcSEcCtD
Flecainide—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00553	0.00553	CcSEcCtD
Flecainide—Headache—Hydrochlorothiazide—nephrolithiasis	0.0055	0.0055	CcSEcCtD
Flecainide—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00521	CcSEcCtD
